Biden administration reconsidering abortion pill regulations
Pro-abortion groups last week praised the Biden administration for reconsidering federal safety regulations of the abortion pill regimen.
The American College of Obstetricians and Gynecologists (ACOG) on Friday said it was “thrilled” that the U.S. Food and Drug Administration (FDA) was reviewing restrictions on the regimen that have been in place since the year 2000.
The FDA has long required the abortion pill regimen to be dispensed in-person in a health clinic setting, but pro-abortion groups have recently pushed for the pill to be prescribed remotely and dispensed through the mail.
In its statement on Twitter, ACOG supported the FDA’s “evidence-based review” of the “burdensome” and “unnecessary” regulations.
“We are confident that due to the FDA’s commitment to regulatory decision-making that reflects science and patient-centred care, the needless restrictions on #mifepristone will soon end and patients will have less restrictive access to medication abortion & miscarriage care,” ACOG stated on Twitter.
The American Civil Liberties Union called the review “long overdue, but a major move forward.” The group, on behalf of ACOG and other pro-abortion groups, sued the Trump administration last year for leaving the abortion pill regulations in place during the pandemic.